Price Target 5.98

EHE is grossly undervalued. HY earnings to Dec 14 is tracking ahead of IPO for-cast.
For-cast FY 16 div is 6 % FF on todays closing price.
Director spend over $10 m to swop up shares around $4.80 when EHE tanks on IPO


Wilson HTM has
"BUY recommendation and $5.98 price target (in line with our blended valuation). We expect Estia Health’s ~30% FY16F PE discount relative to Regis Healthcare will narrow as Padman, Cook Care and Estia are integrated. There is upside risk to FY15F prospectus forecasts given outperformance on 1H15 costs and net Refundable Accommodation Deposit (RAD) inflows, while occupancy rates and daily revenue per bed are tracking to expectations. We rate the management/board highly, given their prior experience in managing rapid growth at Bupa Australia Aged Care (CEO and CFO), private hospitals (Pat Grier) and retirement villages (Norah Barlow0"